Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a98:d84b:0:b0:1eb:e128:bbe3 with SMTP id b11csp500830eil;
        Thu, 18 Jan 2024 11:48:19 -0800 (PST)
X-Google-Smtp-Source: AGHT+IGsnhyVSJ8MNgemJNeXA7NzCghoe6gVXkZeIWpSUAR+cHXFPErg6aJiEBuK8d9f3TnfMf5X
X-Received: by 2002:a05:620a:1daa:b0:783:200d:5e09 with SMTP id pj42-20020a05620a1daa00b00783200d5e09mr188722qkn.22.1705607298950;
        Thu, 18 Jan 2024 11:48:18 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705607298; cv=none;
        d=google.com; s=arc-20160816;
        b=Lhw6bT4GiCCX4m4q7/2M80G1F+mea8cz1zrEvRvZvfD82OpQX/KK0EmyJzK4kuR+Wk
         YgZNj0/QD5Ouv/PpZwbCiEfmkK/XIeILKEhz1h5XxRZLWlVOcTArRRgySH9wE3HPBVgx
         Eu78yVAMiYZxfJcPllqNwg2r9pD7mJfKsVlMYg+oDkPogQxdGi2rz5jlU3zU/YYjwTlj
         v20EA3J65oWKMJZWEliMqLHz+TQINfPxGe/JNIHTFbDkXiWxdILTQb83jergrDyzJcjM
         EcLVVh1G5Qnd4Ue3YTFJ/+r44ARcLv8HBltc4BC/9MvsaXopOeTOtdPrKojudqkO8Fdw
         UFYg==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=2dAEWhy+3QuJE2QI5Bq+9ezVSkqQq1zTkFPVOwtuUBs=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=0DWmqbKYgCdh+sf0imDLdw/OTxldQ94x/azU1zPcqAAY9UbLMtr9gfye8WZm1dauOS
         Cj9MNHOeTp+rg1tshLCLfqgzwEJjuw78lybi/M9ngAYuE2yGdot2EXBUIm8Kovsw4nMz
         Vv3m5pttOP1ujRzqDKWLSTmvxQQAHkW06HW0wNmuMIVEib5VP5o2BK2UQ1fj/oDcXzGf
         hL/8NZPfUb+2Y51c1emMUaimwoXkzGmg1sS8XI3yXlZiZdS6r5f612pbc08cAohs4jYg
         sVTBnEutzVHFCn/K/VTLmzpx1grZLMxFzSL6ucfFMynx/oJIAiK5XLdhwJjc4p42d6tO
         WwwA==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=jAT1VZA4;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b="mi476xm/";
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id l8-20020a37f508000000b007833c8370fcsi13951761qkk.636.2024.01.18.11.48.18
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Thu, 18 Jan 2024 11:48:18 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=jAT1VZA4;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b="mi476xm/";
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=2dAEWhy+3QuJE2QI5Bq+9ezVSkqQq1zTkFPVOwtuUBs=;
	b=jAT1VZA4Dy76sX7tIcJb8fYpjmm4NUNJV/q4wxV8DCZV6JMAmjNus22KvEQbNUDDyZYu
	Ze016Jlo0POArJTL4PEPwuKYhWICV/DBaP+J41yxl2TMOiwQYTk5UmapgIKX6C/bjdTnDd
	frw1nEEFFgtKZ1yywFFj1drCgUQtZt1ztrC57dHSAZG6CnpEludFvF5PGfaKSVcqfXEaXT
	pX8/ljth/KyBgTjnTQiQN1BvcL8h6HyicBZsDrn+Mr4hm8B/qWiQHE3ii41qQdsukmwZTt
	eWn3Bd7MHQzmZt0rzWiyyGtRe7S38uw+fvPGSGgxEx0x4RigeCE/NL0M7b+p4/UQ==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=2dAEWhy+3QuJE2QI5Bq+9ezVSkqQq1zTkFPVOwtuUBs=;
	b=mi476xm/pBXwSvdcHifx40lhpWvBIQM+r9gTfftcM5d70zY33yAChb0hf9NMDMriG8om
	ueckIb0gkUke/Md0KQjyH097tBei4UcIdo1iw4cXj1pjMoPLeoc2U8S9O/Nqm59myhZUkA
	vJQyoYaZUo79CmOlxGdmnwAkD86X+8tSs=
Received: by filterdrecv-697c458b48-kqrqg with SMTP id filterdrecv-697c458b48-kqrqg-1-65A98080-73
        2024-01-18 19:48:16.866502143 +0000 UTC m=+7394527.170865537
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-30 (SG) with HTTP
	id k9eV2CgGRxGVYSwBtHJcow
	Thu, 18 Jan 2024 19:48:16.854 +0000 (UTC)
Content-Type: multipart/alternative; boundary=aa481e638617dae4eda519fef1cefe6ba7b1d5ba9ba34adebd2428a68018
Date: Thu, 18 Jan 2024 19:48:18 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <k9eV2CgGRxGVYSwBtHJcow@geopod-ismtpd-30>
Subject: PRO/EDR> Malaria - Argentina: (Buenos Aires) imported, USA citizen,
 fatal
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBNR8ua8L4T+Gf36NGlXl+s4Tx+FyEndRoWQ+GF?=
 =?us-ascii?Q?IC9ripvBKZm4L9VFSXYyAZFjPNySYjxKBvbZWGE?=
 =?us-ascii?Q?jXC4Pq9CHKXDJmSy7Ib32gzTow5RPqcKkrREDnW?=
 =?us-ascii?Q?DcuXs2vuyzt7O5GFYO+i1eMdkgnsqh=2F4MA33UtX?=
 =?us-ascii?Q?otpS594qCN+DmZ=2FbSnfFSmJXVlc9YUANIvQUAS?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUhc93xcG=2F095a5S4+mt=2FG?=
 =?us-ascii?Q?uYUpctI=2FOGD2dwyi+uvm2j4FCdvuw0l9zcHM8iA?=
 =?us-ascii?Q?mojOvTXq7jOpDFFNtfsYkHQYACEW8pq1BXXqYmH?=
 =?us-ascii?Q?oGTsnt6QpE2ZV5WVqnpwfXWoLXx7+4boGW=2FSTPF?=
 =?us-ascii?Q?=2FfTf739riDcOpPMSqei9kKFFaYsUh2EskXercGA?=
 =?us-ascii?Q?kIEO+Jia5F7yFM+lkx8tjaPwNnHPkcFLBAH7Dp6?=
 =?us-ascii?Q?g2aAsBZWDCxSuelD72M0YzKC4mN5ReSi2R8ZQ9h?=
 =?us-ascii?Q?HvVit9Y2uNwCi=2FmU7YWcMqsodPNX8s5m5hD0XAU?=
 =?us-ascii?Q?Uydwjz+McW2VoJevU59BVKfBk2RakRUsIJmwBFG?=
 =?us-ascii?Q?y16AEdWd5dhxmzNSKmGgMQtLNJ+eFUxrfhTzWnF?=
 =?us-ascii?Q?jgVdta3=2FH0Mz8mUf55=2Fl4Y5GH+GtNEG78wgK4OA?=
 =?us-ascii?Q?iZ80+QXEChictITTSoyomgg7HmK6RkQBg9wm=2FP2?=
 =?us-ascii?Q?ZsmdxsuDBZe1oOx+qXx+fKr6jr2XOgCcjwxn075?=
 =?us-ascii?Q?jyTHIK+yzZ+9Gz9iYJtix9EqqPEvFVR7bpZJmsF?=
 =?us-ascii?Q?Qd7I3vPYRBlwZhxPgffMtfjl9p+nmXYQ7EfGEyy?=
 =?us-ascii?Q?=2FlrR7GAx3SKT9bX1TGyJL5ZwYlexBjUqDT4sTwN?=
 =?us-ascii?Q?dFFg+H2Xd9Os7ieatYPKE6ZmWh0YcstcmFT4V42?=
 =?us-ascii?Q?2sDybhjHtcR5YJLoVps5AkkA9=2FUTCQcwhATT35z?=
 =?us-ascii?Q?WzBeQS1919YbEpOK6NNlv2F=2FKC=2Fvun8YlB=2FDV3d?=
 =?us-ascii?Q?26G3WczYL2znv0IphddiNyWX4Q=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2EWgMY1Eeyy?=
 =?us-ascii?Q?oVZrrUGPjhehu-w=5FBhRYTr=5FgCPVasjhl6xoMDAw?=
 =?us-ascii?Q?dTAwMFMlFGOKMKzScGT5ZbYYYzGNlhVJU2lgITp?=
 =?us-ascii?Q?w5XiFtmSH2VUdr6q-AkOysniHPa0tjU0N5167id?=
 =?us-ascii?Q?LADTTCZkuKk8Nxdh6nP1grdd-UeTZ8zEYYn4G8H?=
 =?us-ascii?Q?KalFj=5FMEIAPb3UcOQ=3D=3D=2E=5FZT8uvKNhIvJyyrrrq9?=
 =?us-ascii?Q?LzsD0xsltEyxYH2-Z-yGA-ftoMDAwdTAwMMZsHE?=
 =?us-ascii?Q?3vLq5KbfXm52O2eM7HJaDAa7LR64hlsxpk3g0yV?=
 =?us-ascii?Q?lafi-xCT=5FnnhKmT-x0BX88FgVPhEkBEuc9WBQDj?=
 =?us-ascii?Q?Z1F-Af=5FOlDfyhVUFQJejjDJh-DnOlaOpeFLRXZF?=
 =?us-ascii?Q?TUFymrIbdFfEoJNAPGbVWh0=5F7U6limI4XU6PTKb?=
 =?us-ascii?Q?cH5RQCq=5FLUkY9qZsZbFDy5UMlSR7IRbJHifmgPR?=
 =?us-ascii?Q?DmaL2ZavV6Hhd2QsA2gRXFIKrvfsBSjFQBM=5Ft2Q?=
 =?us-ascii?Q?96bMDyRfMQG8uhFquq62RwPyM-pgJdLx2epBi0G?=
 =?us-ascii?Q?8049vaTVYX=5FpH2E90JAh=5FEYiRgAqgBB7x7vmwnG?=
 =?us-ascii?Q?KkrwZOiPsppt6WJisxPKb18d8zsGjvrorfGnvpZ?=
 =?us-ascii?Q?WY0IRALejlDBlV9Zs2bK3MyBx9zI0LVub9LK9Ew?=
 =?us-ascii?Q?uNcU4JJbD5jdAmXec84JUpI5Le5p9hW-9qzzJA=5F?=
 =?us-ascii?Q?f2NDCBe-NgWeHCKhyieJm=5FtmHm3WVjrBheJHAaN?=
 =?us-ascii?Q?e1MoqX5FLUIa6uHLSnr3M3LO5ZVJXFYCLS0lkiu?=
 =?us-ascii?Q?qwqqCKPsBrXS5nuFFw43If3or7qkGlp5pFvr929?=
 =?us-ascii?Q?ybhM17bk=5FPlTYrJ2U618G=5FiS2uVhI4POrikZf9F?=
 =?us-ascii?Q?rKGiDT7Adhn3G=5F7MViwYGCtQgfkz5UN-RIIMirO?=
 =?us-ascii?Q?Ft1lShYDgN03GXlKSRLvhTmj23uLlFaa9lQW3jU?=
 =?us-ascii?Q?0RCQRb2vU-2xg03bYG8Dm-s2qdZzKktm2aTNs-D?=
 =?us-ascii?Q?xdsmWSZgSGAj5Dl1Tls5vD0I-7-T6tSd1D2XE-s?=
 =?us-ascii?Q?jPfhOVcYACQ4kYEPRklfk=5FWKUNcrxPfM-z9IzU9?=
 =?us-ascii?Q?pyiGx0MdR9XGJXelkSsmx28QgRWCO9KcMOO=5Feyk?=
 =?us-ascii?Q?oTr8tRWbGZojc7OnOKKTFLwdvoLoxNaW=5FQiKlVf?=
 =?us-ascii?Q?Aahy2aXkJrcG5p055POex2SZvEOUoC0zCRnPhXe?=
 =?us-ascii?Q?gj3buiQUnPK1B6XDVKhRTyA78tR9jslUuLhlka=5F?=
 =?us-ascii?Q?7EXZba5Ako8P8g5Qsfb7kgMYqulHG3FOmzLTR0v?=
 =?us-ascii?Q?1rPDMeM4WNbsvJlTYJPyK-6=3E?=

--aa481e638617dae4eda519fef1cefe6ba7b1d5ba9ba34adebd2428a68018
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=iso-8859-1
Mime-Version: 1.0

MALARIA - ARGENTINA: (BUENOS AIRES) IMPORTED, USA CITIZEN, FATAL
****************************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Tue 16 Jan 2024
Source: Clar=EDn, Argentina [in Spanish, machine trans., edited]
<https://www.clarin.com/sociedad/turista-estadounidense-murio-malaria-hospi=
tal-fernandez_0_VidGmllBJD.html>


An 80-year-old tourist and former judge in the state of Oregon, United
States, died of malaria at the Fern=E1ndez Hospital in the City of
Buenos Aires. The man was urgently admitted to the Buenos Aires
facility and died a few minutes later. As confirmed to Clar=EDn by the
City Ministry of Health, the retired judge was treated at Fern=E1ndez
on 7 Jan 2024. He was returning from Ushuaia [the capital of Tierra
del Fuego in the south of Argentina - Mod.LL], but previously he
passed through several countries, so there is no data yet on where he
contracted the disease.

"It is not known where he caught it (malaria) because he was in
different destinations, such as Istanbul, India, and Ethiopia. He
arrived at the facility and died half an hour later," Fern=E1ndez told
this newspaper.

The United States embassy and consulate are closely monitoring this
death.

The patient arrived in a serious state of health, with high fever,
severe anemia, and hypoglycemia. He was intubated and died after an
hour.

As a result of the in-depth study carried out at the Malbr=E1n
Institute, it was confirmed that the cause of death was malaria.
Mainly, the symptoms of this parasitic infection are fever, chills,
general malaise, and headache. There are different treatment schemes
depending on the type of parasite that caused the disease.

Prevention, if you travel to malaria circulation areas, is to protect
yourself with repellent and wear long sleeves and pants that cover
your ankles to avoid being bitten by this mosquito [and to use
appropriate antimalarial prophylaxis - Mod.LL].

The WHO certified in May 2019 that Argentina is a malaria-free
country. There have been no indigenous cases since 2011. The last
outbreak recorded in the country was in the province of Misiones in
2007.

--
Communicated by:
ProMED
via
ProMED-ESP

[There are a number of pieces of information that are needed to
clarify the course of illness in this case, much of which may never be
known:

1. The individual's exact travel itinerary
2. If any antimalarial prophylaxis was used
3. If the person was educated in the use of prophylaxis for malaria
4. When the illness began, and if the person was seen by a health-care
worker earlier in his illness

Falciparum, the cause of so-called malignant tertian malaria, accounts
for a higher case-fatality rate with much higher degrees of
parasitemia and was likely the species of _Plasmodium_ involved.
Additionally, this species is much more likely to be drug-resistant
than the other species.

A recent review of malaria overall follows:

Poespoprodjo JR, Douglas NM, Ansong D, et al. Malaria. Lancet. 2023;
402(10419): 2328-2345;
<https://doi.org/10.1016/S0140-6736(23)01249-7>.
---------------------------------------------------------------------------=
----------------------------------
Abstract
--------
"Malaria is resurging in many African and South American countries,
exacerbated by COVID-19-related health service disruption. In 2021,
there were an estimated 247 million malaria cases and 619 000 deaths
in 84 endemic countries. _Plasmodium falciparum_ strains partly
resistant to artemisinins are entrenched in the Greater Mekong region
and have emerged in Africa, while _Anopheles_ mosquito vectors
continue to evolve physiological and behavioural resistance to
insecticides. Elimination of _Plasmodium vivax_ malaria is hindered by
impractical and potentially toxic antirelapse regimens.
Parasitological diagnosis and treatment with oral or parenteral
artemisinin-based therapy is the mainstay of patient management.
Timely blood transfusion, renal replacement therapy, and restrictive
fluid therapy can improve survival in severe malaria. Rigorous use of
intermittent preventive treatment in pregnancy and infancy and
seasonal chemoprevention, potentially combined with pre-erythrocytic
vaccines endorsed by WHO in 2021 and 2023, can substantially reduce
malaria morbidity. Improved surveillance, better access to effective
treatment, more labour-efficient vector control, continued drug
development, targeted mass drug administration, and sustained
political commitment are required to achieve targets for malaria
reduction by the end of this decade."

- Mod.LL

ProMED map:
Buenos Aires, Argentina:
<https://promedmail.org/promed-post?place=3D8714316,53505>]

[See Also:
Malaria - Cape Verde: elimination, WHO
http://promedmail.org/post/20240117.8714283
Malaria - USA (01): (OR) falciparum, probable prolonged presentation,
ex Africa, 2022 http://promedmail.org/post/20240113.8714202
Malaria - Tanzania: (Zanzibar) re-emergence
http://promedmail.org/post/20240113.8714213
2023
----
Malaria - Asia (09): India (WB)
http://promedmail.org/post/20231215.8713751
Malaria - Asia (07): India (TR) increased cases
http://promedmail.org/post/20231018.8712705
Malaria - Americas (16): USA (MD) autochthonous, falciparum, CDC
http://promedmail.org/post/20231012.8712600
Malaria - Americas (15): (Canada) ex Philippines, Plasmodium knowlesi
http://promedmail.org/post/20231007.8712508
Malaria - Americas (14): USA (AR) autochthonous
http://promedmail.org/post/20231005.8712469
Malaria - Africa (07): Ethiopia (OR) continued increase, RFI
http://promedmail.org/post/20231001.8712408
Malaria - Americas (13): Costa Rica (PU)
http://promedmail.org/post/20230929.8712370
Malaria - Americas (12): USA (FL, TX) CDC
http://promedmail.org/post/20230908.8712013
Malaria - Americas (11): USA (MD) 1st report in 40 years
http://promedmail.org/post/20230819.8711760
Malaria - Americas (11): Colombia, increase in incidence
http://promedmail.org/post/20230723.8711323
Malaria - Americas (10): USA (FL) autochthonous
http://promedmail.org/post/20230718.8711230
Malaria - Americas (09): USA (FL, TX) autochthonous, update
http://promedmail.org/post/20230709.8711042
Malaria - Africa (06): Ethiopia, increase, RFI
http://promedmail.org/post/20230706.8710994
Malaria - Americas (08): USA (FL, TX) autochthonous, CDC, alert
http://promedmail.org/post/20230629.8710856
Malaria - Americas (07): USA (TX) autochthonous
http://promedmail.org/post/20230625.8710761
Malaria - Americas (06): USA (FL) autochthonous, RFI
http://promedmail.org/post/20230623.8710719
Malaria - Africa (05): Kenya (MB) fatal, not linked to Anopheles
stephensi http://promedmail.org/post/20230524.8710210
Malaria - Africa (04): Kenya (BN), Congo DR (KS), Nigeria (AN), Ghana
http://promedmail.org/post/20230502.8709805
Malaria - Americas (05): Colombia, Venezuela
http://promedmail.org/post/20230501.8709785
Malaria - Americas (04): USA, imported, ex Liberia, fatal
http://promedmail.org/post/20230427.8709737
Malaria - Americas (03): (Costa Rica, Panama)
http://promedmail.org/post/20230424.8709665
Malaria - Americas (02): Costa Rica (LI)
http://promedmail.org/post/20230409.8709416
Malaria - Americas: Panama, increase
http://promedmail.org/post/20230315.8708952]
.................................................jt/ll/tw/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DLkUNSpz835fLzJhNlU4IAG04yMIqTNhNakfO9XagL2doMDAwdTAwMMWl8cu=
rhv-Ehp-hkb8DFuvw0Tt0CMab94Cg-CPptaDUINLbtNXlFcFdaDxGxcZCVegHuseE00NCDQK97d=
24PI476gMiwkpwlMU8sF03uKM8uM4oC-kbQ9LTk8aJI9oPN0NbqPoCnHB4QMGW-ql6fjHebfL0p=
73shyxrtXoWbtHdKdQlrtDNfB9DqOs4m8-6MK4lbFX--GgmOUArQOqJqs5EAuGulpigZTgq2GW1=
NJaNAewuY-hM6T-U-d8m7useBdI0BzbKESp0anestUzPDV1Kw4kle1j7LCaAEak2U5gV0YBD1vt=
4yoAQbpeDegsLmunvcbVbFW813IkpyKhahg00lVfeCFj08kFKdUlZc8eGNvKw6LF7kMSKKsuadR=
hWjrGDl3zt5vEcvCVQW5t7EtHk9iaKfU_-kkspqgsqB9pMjcoeQ0bmEsMpZRg0A8JiJw_ZO3ynh=
lVHXu6YCiGCydNXVsJGipdY4oQyAjDS2MHOFM_MYv5HzPNtzPZkV5VG2KmxHnbULBZIY5h8rQL6=
El_odTXA-O72f3d9dlRX3b3sVcLF2zv7LGKm1LbZWyOoW5mHKL4zQPbsIj9lfFGo5n8SdLk3vjZ=
Nijycy1Y322cpU_ZNyl1Hm4brT5z6IK4ok0RUo2AnMQXstNO13xnpFdVaJ_eXBEeCEeGpjwuVt_=
6sTmTLLv7xPjNSWGW9uf-Ht59x256ab41NGe9Tb1eKeUvzTJnvmOhA1vRCUznx-Et-1pzhv5WGh=
J3wcf921E-hdbEc55rL4wsZYfEWu9szrM8PewbLDCo6-mucBqBS6rv5Uxh5ChgA3LOH8kJQ03Fy=
ZgrFGrBbRWEENE2ZhYUJXfwE-_OhfBxdSswZgEPaHxJeQ9D1Ifa5QeGlGFDtDNpdHLzKGoAAmcW=
yC52OImBSRK9EC80l3QKwNeSMz87KeJwahVRxNQMuw-Zl-N78bsT09ojC4xeWrcniid9woa1Frl=
ms-8E-pdBKnhGbIIr9s3dFTYou6mHe-oPBE5jC7BvzY52lFsh2JcaputTOl7S-jQeljrT2seZZG=
9biXj-kfXhkMeYaWVC_qqcw7TYttZP52xXiac_rLcBPnP7j14KRigAdCAPCStyHmMFIJ6eEBDUD=
hBZMiHWtRCperwBANyi7oLoIftgHLM4TMVZlcBi9B1A=3D )
############################################################
############################################################

--aa481e638617dae4eda519fef1cefe6ba7b1d5ba9ba34adebd2428a68018
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=iso-8859-1
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>MALARIA - ARGENTINA: (BUENOS AIRES) IMPORTED, USA CITIZEN, FATAL<br>*=
***************************************************************<br>A ProMED=
-mail post<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/wscE2ng5fl6=
JrPIt48tisIijpefK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2Tfv3HA/433/2h1XPOEnQUGaDbafI=
wF5Vw/h0/a7YK0iPXAnEm-PcCoD7BkmtbRUGkDM_ZILxSV6pQAAo">http://www.promedmail=
.org</a><br>ProMED-mail is a program of the<br>International Society for In=
fectious Diseases<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/wscE=
2ng5fl6JrPIt48tisCT5tpD4Upm3qyMCbcYSQvc/433/2h1XPOEnQUGaDbafIwF5Vw/h1/0kdWh=
DoVMpUpf0P9YIfMOf06tksTcTiV10wahZRHM7Y">http://www.isid.org</a><br><br>Date=
: Tue 16 Jan 2024=0D<br>Source: Clar=EDn, Argentina [in Spanish, machine tr=
ans., edited]=0D<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/TLh_c=
srC34X_iXpbYoMam3DGXxlfEeJ-y56Pz83tYEK5-1m9MPKpmJlqziw6A2DOzEOLhrP8W_wYvPpC=
IjcnxrvblDo28OpFJV73_jMHEL2VpXBvWov4kedKwQHX3r2k0LEPwPlyfCEEm9sEySEDJO88Q0x=
Km8iN3cE403GOO_A/433/2h1XPOEnQUGaDbafIwF5Vw/h2/IvtB6C5FxSIfdzFZhN-GdXAUy7Dd=
lIOhdml_bWdnCpw">https://www.clarin.com/sociedad/turista-estadounidense-mur=
io-malaria-hospital-fernandez_0_VidGmllBJD.html</a>=0D<br>=0D<br>=0D<br>An =
80-year-old tourist and former judge in the state of Oregon, United<br>Stat=
es, died of malaria at the Fern=E1ndez Hospital in the City of<br>Buenos Ai=
res. The man was urgently admitted to the Buenos Aires<br>facility and died=
 a few minutes later. As confirmed to Clar=EDn by the<br>City Ministry of H=
ealth, the retired judge was treated at Fern=E1ndez<br>on 7 Jan 2024. He wa=
s returning from Ushuaia [the capital of Tierra<br>del Fuego in the south o=
f Argentina - Mod.LL], but previously he<br>passed through several countrie=
s, so there is no data yet on where he<br>contracted the disease.=0D<br>=0D=
<br>"It is not known where he caught it (malaria) because he was in<br>diff=
erent destinations, such as Istanbul, India, and Ethiopia. He<br>arrived at=
 the facility and died half an hour later," Fern=E1ndez told<br>this newspa=
per.=0D<br>=0D<br>The United States embassy and consulate are closely monit=
oring this<br>death.=0D<br>=0D<br>The patient arrived in a serious state of=
 health, with high fever,<br>severe anemia, and hypoglycemia. He was intuba=
ted and died after an<br>hour.=0D<br>=0D<br>As a result of the in-depth stu=
dy carried out at the Malbr=E1n<br>Institute, it was confirmed that the cau=
se of death was malaria.<br>Mainly, the symptoms of this parasitic infectio=
n are fever, chills,<br>general malaise, and headache. There are different =
treatment schemes<br>depending on the type of parasite that caused the dise=
ase.=0D<br>=0D<br>Prevention, if you travel to malaria circulation areas, i=
s to protect<br>yourself with repellent and wear long sleeves and pants tha=
t cover<br>your ankles to avoid being bitten by this mosquito [and to use<b=
r>appropriate antimalarial prophylaxis - Mod.LL].=0D<br>=0D<br>The WHO cert=
ified in May 2019 that Argentina is a malaria-free<br>country. There have b=
een no indigenous cases since 2011. The last<br>outbreak recorded in the co=
untry was in the province of Misiones in<br>2007.=0D<br>=0D<br>--=0D<br>Com=
municated by:=0D<br>ProMED=0D<br>via=0D<br>ProMED-ESP<br><br>[There are a n=
umber of pieces of information that are needed to<br>clarify the course of =
illness in this case, much of which may never be<br>known:=0D<br>=0D<br>1. =
The individual's exact travel itinerary=0D<br>2. If any antimalarial prophy=
laxis was used=0D<br>3. If the person was educated in the use of prophylaxi=
s for malaria=0D<br>4. When the illness began, and if the person was seen b=
y a health-care<br>worker earlier in his illness=0D<br>=0D<br>Falciparum, t=
he cause of so-called malignant tertian malaria, accounts<br>for a higher c=
ase-fatality rate with much higher degrees of<br>parasitemia and was likely=
 the species of _Plasmodium_ involved.<br>Additionally, this species is muc=
h more likely to be drug-resistant<br>than the other species.=0D<br>=0D<br>=
A recent review of malaria overall follows:=0D<br>=0D<br>Poespoprodjo JR, D=
ouglas NM, Ansong D, et al. Malaria. Lancet. 2023;<br>402(10419): 2328-2345=
;<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/TUIVIg4PCmni5tP3Q8lz=
Bb5MugwcowHsZrFMKbC9gdZi6zW0EXYGAeennnaAOgG9MBzhBbewlLr3EFwaF3sPnw/433/2h1X=
POEnQUGaDbafIwF5Vw/h3/Q8TNwiS6JgeN1LOTj6ebZhFac52_12vaIQUfb3erErA">https://=
doi.org/10.1016/S0140-6736(23)01249-7</a>.=0D<br>--------------------------=
---------------------------------------------------------------------------=
--------=0D<br>Abstract=0D<br>--------=0D<br>"Malaria is resurging in many =
African and South American countries,<br>exacerbated by COVID-19-related he=
alth service disruption. In 2021,<br>there were an estimated 247 million ma=
laria cases and 619 000 deaths<br>in 84 endemic countries. _Plasmodium falc=
iparum_ strains partly<br>resistant to artemisinins are entrenched in the G=
reater Mekong region<br>and have emerged in Africa, while _Anopheles_ mosqu=
ito vectors<br>continue to evolve physiological and behavioural resistance =
to<br>insecticides. Elimination of _Plasmodium vivax_ malaria is hindered b=
y<br>impractical and potentially toxic antirelapse regimens.<br>Parasitolog=
ical diagnosis and treatment with oral or parenteral<br>artemisinin-based t=
herapy is the mainstay of patient management.<br>Timely blood transfusion, =
renal replacement therapy, and restrictive<br>fluid therapy can improve sur=
vival in severe malaria. Rigorous use of<br>intermittent preventive treatme=
nt in pregnancy and infancy and<br>seasonal chemoprevention, potentially co=
mbined with pre-erythrocytic<br>vaccines endorsed by WHO in 2021 and 2023, =
can substantially reduce<br>malaria morbidity. Improved surveillance, bette=
r access to effective<br>treatment, more labour-efficient vector control, c=
ontinued drug<br>development, targeted mass drug administration, and sustai=
ned<br>political commitment are required to achieve targets for malaria<br>=
reduction by the end of this decade."=0D<br>=0D<br>- Mod.LL<br><br>ProMED m=
ap:<br>Buenos Aires, Argentina:<br><a href=3D"https://u19268662.ct.sendgrid=
.net/ss/c/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4AbwuQ3Z6WbkfhqXYXU-aTMPJ8yThq=
Pmk78U53KMTds7hbQgzJA/433/2h1XPOEnQUGaDbafIwF5Vw/h4/n_BSrU6WG5WNEs6aoXZxiLN=
zLOtIzNHtCOPnV7ET8V4">https://promedmail.org/promed-post?place=3D8714316,53=
505</a>]<br><br>[See Also:<br>Malaria - Cape Verde: elimination, WHO<br>htt=
p://promedmail.org/post/20240117.8714283=0D<br>Malaria - USA (01): (OR) fal=
ciparum, probable prolonged presentation,<br>ex Africa, 2022 http://promedm=
ail.org/post/20240113.8714202=0D<br>Malaria - Tanzania: (Zanzibar) re-emerg=
ence<br>http://promedmail.org/post/20240113.8714213=0D<br>2023=0D<br>----=0D=
<br>Malaria - Asia (09): India (WB)<br>http://promedmail.org/post/20231215.=
8713751=0D<br>Malaria - Asia (07): India (TR) increased cases<br>http://pro=
medmail.org/post/20231018.8712705=0D<br>Malaria - Americas (16): USA (MD) a=
utochthonous, falciparum, CDC<br>http://promedmail.org/post/20231012.871260=
0=0D<br>Malaria - Americas (15): (Canada) ex Philippines, Plasmodium knowle=
si<br>http://promedmail.org/post/20231007.8712508=0D<br>Malaria - Americas =
(14): USA (AR) autochthonous<br>http://promedmail.org/post/20231005.8712469=0D=
<br>Malaria - Africa (07): Ethiopia (OR) continued increase, RFI<br>http://=
promedmail.org/post/20231001.8712408=0D<br>Malaria - Americas (13): Costa R=
ica (PU)<br>http://promedmail.org/post/20230929.8712370=0D<br>Malaria - Ame=
ricas (12): USA (FL, TX) CDC<br>http://promedmail.org/post/20230908.8712013=0D=
<br>Malaria - Americas (11): USA (MD) 1st report in 40 years<br>http://prom=
edmail.org/post/20230819.8711760=0D<br>Malaria - Americas (11): Colombia, i=
ncrease in incidence<br>http://promedmail.org/post/20230723.8711323=0D<br>M=
alaria - Americas (10): USA (FL) autochthonous<br>http://promedmail.org/pos=
t/20230718.8711230=0D<br>Malaria - Americas (09): USA (FL, TX) autochthonou=
s, update<br>http://promedmail.org/post/20230709.8711042=0D<br>Malaria - Af=
rica (06): Ethiopia, increase, RFI<br>http://promedmail.org/post/20230706.8=
710994=0D<br>Malaria - Americas (08): USA (FL, TX) autochthonous, CDC, aler=
t<br>http://promedmail.org/post/20230629.8710856=0D<br>Malaria - Americas (=
07): USA (TX) autochthonous<br>http://promedmail.org/post/20230625.8710761=0D=
<br>Malaria - Americas (06): USA (FL) autochthonous, RFI<br>http://promedma=
il.org/post/20230623.8710719=0D<br>Malaria - Africa (05): Kenya (MB) fatal,=
 not linked to Anopheles<br>stephensi http://promedmail.org/post/20230524.8=
710210=0D<br>Malaria - Africa (04): Kenya (BN), Congo DR (KS), Nigeria (AN)=
, Ghana<br>http://promedmail.org/post/20230502.8709805=0D<br>Malaria - Amer=
icas (05): Colombia, Venezuela<br>http://promedmail.org/post/20230501.87097=
85=0D<br>Malaria - Americas (04): USA, imported, ex Liberia, fatal<br>http:=
//promedmail.org/post/20230427.8709737=0D<br>Malaria - Americas (03): (Cost=
a Rica, Panama)<br>http://promedmail.org/post/20230424.8709665=0D<br>Malari=
a - Americas (02): Costa Rica (LI)<br>http://promedmail.org/post/20230409.8=
709416=0D<br>Malaria - Americas: Panama, increase<br>http://promedmail.org/=
post/20230315.8708952]<br>.................................................=
jt/ll/tw/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DLkUNSpz835fLzJhNlU4IAG04yMIqTNhNakfO9XagL2doMDAwdT=
AwMMWl8curhv-Ehp-hkb8DFuvw0Tt0CMab94Cg-CPptaDUINLbtNXlFcFdaDxGxcZCVegHuseE0=
0NCDQK97d24PI476gMiwkpwlMU8sF03uKM8uM4oC-kbQ9LTk8aJI9oPN0NbqPoCnHB4QMGW-ql6=
fjHebfL0p73shyxrtXoWbtHdKdQlrtDNfB9DqOs4m8-6MK4lbFX--GgmOUArQOqJqs5EAuGulpi=
gZTgq2GW1NJaNAewuY-hM6T-U-d8m7useBdI0BzbKESp0anestUzPDV1Kw4kle1j7LCaAEak2U5=
gV0YBD1vt4yoAQbpeDegsLmunvcbVbFW813IkpyKhahg00lVfeCFj08kFKdUlZc8eGNvKw6LF7k=
MSKKsuadRhWjrGDl3zt5vEcvCVQW5t7EtHk9iaKfU_-kkspqgsqB9pMjcoeQ0bmEsMpZRg0A8Ji=
Jw_ZO3ynhlVHXu6YCiGCydNXVsJGipdY4oQyAjDS2MHOFM_MYv5HzPNtzPZkV5VG2KmxHnbULBZ=
IY5h8rQL6El_odTXA-O72f3d9dlRX3b3sVcLF2zv7LGKm1LbZWyOoW5mHKL4zQPbsIj9lfFGo5n=
8SdLk3vjZNijycy1Y322cpU_ZNyl1Hm4brT5z6IK4ok0RUo2AnMQXstNO13xnpFdVaJ_eXBEeCE=
eGpjwuVt_6sTmTLLv7xPjNSWGW9uf-Ht59x256ab41NGe9Tb1eKeUvzTJnvmOhA1vRCUznx-Et-=
1pzhv5WGhJ3wcf921E-hdbEc55rL4wsZYfEWu9szrM8PewbLDCo6-mucBqBS6rv5Uxh5ChgA3LO=
H8kJQ03FyZgrFGrBbRWEENE2ZhYUJXfwE-_OhfBxdSswZgEPaHxJeQ9D1Ifa5QeGlGFDtDNpdHL=
zKGoAAmcWyC52OImBSRK9EC80l3QKwNeSMz87KeJwahVRxNQMuw-Zl-N78bsT09ojC4xeWrcnii=
d9woa1Frlms-8E-pdBKnhGbIIr9s3dFTYou6mHe-oPBE5jC7BvzY52lFsh2JcaputTOl7S-jQel=
jrT2seZZG9biXj-kfXhkMeYaWVC_qqcw7TYttZP52xXiac_rLcBPnP7j14KRigAdCAPCStyHmMF=
IJ6eEBDUDhBZMiHWtRCperwBANyi7oLoIftgHLM4TMVZlcBi9B1A=3D" target=3D"_blank" =
class=3D"Unsubscribe--unsubscribePreferences" style=3D"font-family:sans-ser=
if;text-decoration:none;">Unsubscribe Preferences</a></div><br>############=
################################################<br>#######################=
#####################################<br><br><img src=3D"https://u19268662.=
ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/433/2h1XPOEnQUGaDbafIwF5Vw/ho.g=
if" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=3D"height:1px !imp=
ortant;width:1px !important;border-width:0 !important;margin-top:0 !importa=
nt;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !impo=
rtant;padding-top:0 !important;padding-bottom:0 !important;padding-right:0 =
!important;padding-left:0 !important;"/></body>
</html>
--aa481e638617dae4eda519fef1cefe6ba7b1d5ba9ba34adebd2428a68018--
